Invention Grant
- Patent Title: Compositions and methods of Rit1 inhibition
-
Application No.: US15738353Application Date: 2016-06-29
-
Publication No.: US10525040B2Publication Date: 2020-01-07
- Inventor: Shahrooz Rabizadeh , Oleksandr Buzko , Paul Weingarten , Heather McFarlane , Connie Tsai , Stephen Charles Benz , Kayvan Niazi , Patrick Soon-Shiong
- Applicant: NANTBIO, INC. , NANTOMICS, LLC , NANT HOLDINGS IP, LLC
- Applicant Address: US CA Culver City US CA Culver City US CA Culver City
- Assignee: NantBio, Inc.,NantOmics, LLC,Nant Holdings IP, LLC
- Current Assignee: NantBio, Inc.,NantOmics, LLC,Nant Holdings IP, LLC
- Current Assignee Address: US CA Culver City US CA Culver City US CA Culver City
- Agency: Lucas & Mercanti, LLP
- International Application: PCT/US2016/040212 WO 20160629
- International Announcement: WO2017/004274 WO 20170105
- Main IPC: A61K31/4196
- IPC: A61K31/4196 ; A61K45/06 ; A61K31/538 ; A61P35/00 ; A61K31/4155 ; A61K31/4178 ; A61K31/4439
Abstract:
Various compounds, compositions, and methods for inhibition of Rit1 are presented. In especially preferred aspects, contemplated compounds and compositions are suitable for treatment of cancers and other diseases associated with Rit1 signaling.
Public/Granted literature
- US20180185335A1 COMPOSITIONS AND METHODS OF RIT1 INHIBITION Public/Granted day:2018-07-05
Information query
